Consistent performance with control where it matters
FRS (Foetal Bovine Serum Replacement Solution) is a chemically defined, animal-free serum replacement designed to support routine cell culture in standard basal media. It delivers reliable, batch-to-batch consistent performance across a broad range of immortalised cell lines, removing the need for serum batch-testing or stockpiling. FRS supports both suspension and adherent systems, with cell attachment handled separately using standard coatings, advanced surface technologies, or chemically defined alternatives. Its defined composition allows researchers to control the presence or absence of biological inputs, such as cytokines or hormones, rather than inheriting undefined serum-derived background. FRS can also be combined with DMSO for use as a freeze medium in routine cryopreservation workflows.
Why scientists switch to FRS?Scientists switch to FRS to eliminate serum variability while retaining control over cell attachment and defined biological inputs across routine culture and assay workflows.
|
What FRS is notFRS is not a cell-type–specific optimised medium, a high-density or biomass-maximisation formulation, or a direct one-to-one substitute for fetal bovine serum for every application.
|
FRS Pioneer vs Fetal Bovine Serum: What you control
With FRS Pioneer:
FRS Pioneer shifts cell culture media from a black box to a controlled input. You trade hidden complexity for explicit, engineerable, and reproducible choice.
- Composition: Fully chemically defined. Every component is known.
- Growth factor & hormone exposure: Fixed, reproducible levels by design.
- Batch-to-batch variability: Minimal.
- Experimental reproducibility: High.
- Regulatory risk: Reduced. No animal-derived inputs.
- Supply risk: Low. Not tied to agricultural supply chains.
- Freeze media use: Compatible with DMSO as a defined freeze medium.
- Adhesion strategy: Explicit and modular. You choose the coating or surface based on your cell type.
- Composition: Undefined and complex. Thousands of components, largely uncharacterised.
- Growth factor & hormone exposure: Unknown and variable.
- Batch-to-batch variability: High. Requires lot testing and stockpiling.
- Experimental reproducibility: Lower. Media composition varies between lots.
- Regulatory risk: Higher. Animal-derived, with traceability and contamination concerns.
- Supply risk: High. Subject to seasonal, geographic, and ethical constraints.
- Freeze media use: Common but undefined.
- Adhesion strategy: Implicit. Serum masks attachment variability rather than controlling it.
FRS Pioneer shifts cell culture media from a black box to a controlled input. You trade hidden complexity for explicit, engineerable, and reproducible choice.
Broad Spectrum - Performance Across Multiple Cell Types
|
Chemically Defined - Unparalleled Reproducibility
|
Contaminant Free
|
Cost Effective - Priced on par with Premium FBS
|
